Personalis - PSNL Stock Forecast, Price & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Personalis in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PSNL shares.
View PSNL analyst ratings or view top-rated stocks.

4 Wall Street research analysts have issued 12-month target prices for Personalis' shares. Their PSNL share price forecasts range from $5.00 to $11.00. On average, they predict the company's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 198.5% from the stock's current price.
View analysts price targets for PSNL or view top-rated stocks among Wall Street analysts.

Personalis' stock was trading at $1.98 on January 1st, 2023. Since then, PSNL stock has increased by 35.4% and is now trading at $2.68.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our PSNL earnings forecast.

Personalis, Inc. (NASDAQ:PSNL) released its earnings results on Thursday, February, 23rd. The company reported ($0.67) EPS for the quarter, missing the consensus estimate of ($0.65) by $0.02. The firm earned $16.72 million during the quarter. Personalis had a negative trailing twelve-month return on equity of 44.79% and a negative net margin of 174.21%.

ETFs with the largest weight of Personalis (NASDAQ:PSNL) stock in their portfolio include ARK Genomic Revolution ETF (ARKG) and Invesco Nasdaq Future Gen 200 ETF (QQQS).AXS Green Alpha ETF (NXTE).

Personalis issued an update on its first quarter 2023 earnings guidance on Thursday, February, 23rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $17.50 million-$17.50 million, compared to the consensus revenue estimate of $20.60 million.

17 employees have rated Personalis Chief Executive Officer John West on Glassdoor.com. John West has an approval rating of 75% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Personalis investors own include Enphase Energy (ENPH), Pfizer (PFE), Dynavax Technologies (DVAX), QUALCOMM (QCOM), Advanced Micro Devices (AMD), NIO (NIO), NVIDIA (NVDA), Viking Therapeutics (VKTX), AbbVie (ABBV) and

(PSNL) raised $100 million in an initial public offering on Thursday, June 20th 2019. The company issued 6,700,000 shares at $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Cowen and Company acted as the underwriters for the IPO and Oppenheimer was co-manager.

Personalis trades on the NASDAQ under the ticker symbol "PSNL."

Personalis' stock is owned by a number of institutional and retail investors. Top institutional shareholders include ARK Investment Management LLC (11.96%), JPMorgan Chase & Co. (7.62%), Alyeska Investment Group L.P. (2.53%), Wellington Shields & Co. LLC (2.20%), Sumitomo Mitsui Trust Holdings Inc. (1.94%) and Nikko Asset Management Americas Inc. (1.94%). Insiders that own company stock include Aaron Tachibana, John Stephen West, Ken Ludlum, Lightspeed Venture Partners Se, Llp Abingworth, Richard Chen and Stephen Michael Moore.
View institutional ownership trends.

Shares of PSNL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PSNL stock can currently be purchased for approximately $2.68.

Personalis (NASDAQ:PSNL) has a market capitalization of $125.26 million and generates $65.05 million in revenue each year. The company earns $-113,320,000.00 in net income (profit) each year or ($2.48) on an earnings per share basis.

The company employs 325 workers across the globe.

Personalis' mailing address is 1330 O`BRIEN DRIVE, MENLO PARK CA, 94025. The official website for the company is www.personalis.com. The company can be reached via phone at (650) 752-1300 or via email at investors@personalis.com.